Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611210200 on February 6, 2007

J. Biol. Chem., Vol. 282, Issue 14, 10172-10179, April 6, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/14/10172    most recent
M611210200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, Y.
Right arrow Articles by Natarajan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, Y.
Right arrow Articles by Natarajan, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Lysophosphatidic Acid Induces Interleukin-13 (IL-13) Receptor {alpha}2 Expression and Inhibits IL-13 Signaling in Primary Human Bronchial Epithelial Cells*

Yutong Zhao{ddagger}1, Donghong He{ddagger}, Jing Zhao{ddagger}, Lixin Wang§, Alan R. Leff{ddagger}, Ernst Wm. Spannhake, Steve Georas||, and Viswanathan Natarajan{ddagger}

From the {ddagger}Section of Pulmonary and Critical Care, Department of Medicine, University of Chicago, Chicago, Illinois 60637, §Department of Gene Technology, Berlex Bioscience, Richmond, California 94806, Department of Environmental Health Sciences, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205, and ||Division of Pulmonary and Critical Care, Department of Medicine, University of Rochester, Rochester, New York 14627

Interleukin-13 (IL-13), a Th2 cytokine, plays a pivotal role in pathogenesis of bronchial asthma via IL-13 receptor {alpha}1 (IL-13R{alpha}1) and IL-4 receptor {alpha} (IL-4R{alpha}). Recent studies show that a decoy receptor for IL-13, namely IL-13R{alpha}2, mitigates IL-13 signaling and function. This study provides evidence for regulation of IL-13R{alpha}2 production and release and IL-13-dependent signaling by lysophosphatidic acid (LPA) in primary cultures of human bronchial epithelial cells (HBEpCs). LPA treatment of HBEpCs in at imedependent fashion increased IL-13R{alpha}2 gene expression without altering the mRNA levels of IL-13R{alpha}1 and IL-4R{alpha}. Pretreatment with pertussis toxin (100 ng/ml, 4 h) or transfection of c-Jun small interference RNA or an inhibitor of JNK attenuated LPA-induced IL-13R{alpha}2 gene expression and secretion of soluble IL-13R{alpha}2. Overexpression of catalytically inactive mutants of phospholipase D (PLD) 1 or 2 attenuated LPA-induced IL-13R{alpha}2 gene expression and protein secretion as well as phosphorylation of JNK. Pretreatment of HBEpCs with 1 µM LPA for 6 h attenuated IL-13-but not IL-4-induced phosphorylation of STAT6. Transfection of HBEpCs with IL-13R{alpha}2 small interference RNA blocked the effect of LPA on IL-13-induced phosphorylation of STAT6. Furthermore, pretreatment with LPA (1 µM, 6 h) attenuated IL-13-induced eotaxin-1 and SOCS-1 gene expression. These results demonstrate that LPA induces IL-13R{alpha}2 expression and release via PLD and JNK/AP-1 signal transduction and that pretreatment with LPA down-regulates IL-13 signaling in HBEpCs. Our data suggest a novel mechanism of regulation of IL-13R{alpha}2 and IL-13 signaling that may be of physiological relevance to airway inflammation and remodeling.


Received for publication, December 6, 2006 , and in revised form, January 17, 2007.

* This work was supported by National Institutes of Health Grant HL71152 (to V. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Medicine, The University of Chicago, Center for Integrative Science Bldg., Rm. W403M, 929 East 57th St., Chicago, IL 60637. Tel.: 773-834-2385; Fax: 773-834-2687; E-mail: yzhao{at}medicine.bsd.uchicago.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. D. Medoff, A. L. Landry, K. A. Wittbold, B. P. Sandall, M. C. Derby, Z. Cao, J. C. Adams, and R. J. Xavier
CARMA3 Mediates Lysophosphatidic Acid-Stimulated Cytokine Secretion by Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Zheng, W. Liu, S.-Y. Oh, Z. Zhu, B. Hu, R. J. Homer, L. Cohn, M. J. Grusby, and J. A. Elias
IL-13 Receptor {alpha}2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung
J. Immunol., January 1, 2008; 180(1): 522 - 529.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement